epinephrine inhalation aerosol
Sponsors
Amphastar Pharmaceuticals, Inc.
Conditions
AsthmaBronchospasmShortness of BreathWheezing
Phase 1
Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers
CompletedNCT01143051
Start: 2010-01-31End: 2010-06-30Updated: 2018-09-25
Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics
CompletedNCT01188577
Start: 2010-08-31End: 2011-01-31Updated: 2017-07-25
Phase 3
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
CompletedNCT01357642
Start: 2011-07-31End: 2011-12-31Updated: 2016-03-11
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
CompletedNCT01357642
Start: 2011-07-31End: 2011-12-31Updated: 2016-03-11